Anticipating the Future: 5 essential questions to help guide your next eClinical technology purchase - mailchi.mp/trialstat/3goodqu…

Anticipating the Future: A Guide to Smart eClinical Technology Investments trialstat.com/2023/04/antici… #ClinicalResearch #ClinicalTrials #EDC

SkylineDx and NeraCare enter a strategic partnership to advance precision medicine for early-stage melanoma trialstat.com/2023/04/skylin… #ClinicalResearch #ClinicalTrials #Melanoma #MolecularDiagnostic

Intergalactic Therapeutics to Present Updated Data From Its Non-Viral Gene Therapy Platform at the 2023 Retinal Cell and Gene Therapy Innovation Summit trialstat.com/2023/04/interg… #ABCA4Gene #ClinicalResearch #ClinicalTrials #Non-ViralGene

Elucida Oncology Announces Positive Early Phase 1 Safety Data Along with Preclinical Data for the Treatment of Brain Metastases for ELU001, an Anti-Folate Receptor Alpha C’Dot Drug C trialstat.com/2023/04/elucid… #AlphaC’Dot #Anti-FolateReceptor #ClinicalResearch #ClinicalTrials

Oblato Announces the First Enrollment in a Phase 1 Clinical Trial for an Oral Formulation of OKN-007 in Recurrent High-Grade Glioma Patients in the USA trialstat.com/2023/04/oblato… #BrainCancer #ClinicalResearch #ClinicalTrials #Oblato

Totus Medicines Announces First Patient Dosed in Phase 1 Trial of TOS-358 for the Treatment Of Select Solid Tumors trialstat.com/2023/04/totus-… #ClinicalResearch #ClinicalTrials #Phase1 #PI3Kα

Verismo Therapeutics Presents STAR-101 Clinical Trial Design at the Annual Cholangiocarcinoma Foundation Conference trialstat.com/2023/04/verism… #Cholangiocarcinoma #ClinicalResearch #ClinicalTrials #Phase1KIR-CAR

Ocugen Announces Positive Preliminary Safety and Efficacy Results from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa and trialstat.com/2023/04/ocugen… #ClinicalResearch #ClinicalTrials #GeneTherapy #NHRGene

Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 2 Study of AMX0035 for the Treatment of Wolfram Syndrome trialstat.com/2023/04/amylyx… #AMX0035 #AmylyxPharmaceutical #ClinicalResearch #ClinicalTrials

Palisade Bio Announces Enrollment of First Patient in Newsoara Phase 3 Clinical Trial Evaluating LB1148 trialstat.com/2023/04/palisa… #ClinicalResearch #ClinicalTrials #gastrointestinal #LB1148

Alterity Therapeutics Enrolls First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy trialstat.com/2023/04/alteri… #AlterityTherapeutics #ATH434 #ClinicalResearch #ClinicalTrials

Vega Therapeutics Initiates Clinical Trial Program for VGA039, a First‑in‑Class Antibody Therapy for von Willebrand Disease trialstat.com/2023/04/vega-t…‑in‑class-antibody-therapy-for-von-willebrand-disease/ #ClinicalResearch #ClinicalTrials #Phase1 #PressRelease

MAPS PBC Announces Positive Topline Results from Long-Term Observational Follow-Up Study on MDMA-Assisted Therapy for Treatment of PTSD trialstat.com/2023/04/maps-p… #ClinicalResearch #ClinicalTrials #MAPSPBC #MDMA-assistedTherapy

Endogena Therapeutics Completes Dose Escalation in the Phase 1/2a Clinical Trial of EA-2353 for the Treatment of Retinitis Pigmentosa trialstat.com/2023/04/endoge… #ClinicalResearch #ClinicalTrials #EA-2353 #EndogenaTherapeutics

Comanche Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for CBP-4888, an siRNA Investigational Therapy for the Treatment of Preeclampsia trialstat.com/2023/04/comanc… #CBP-4888 #ClinicalResearch #ClinicalTrials #ComancheBiopharma

Vaxcyte Doses First Participants in Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants trialstat.com/2023/04/vaxcyt… #ClinicalResearch #ClinicalTrials #Inc. #Phase2

Seer’s Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progression trialstat.com/2023/04/seers-… #ClinicalResearch #ClinicalTrials #LDHB #LungCancer

Bigfoot Biomedical Acquires Reinforcement Learning Algorithm for Insulin Titration Developed at McGill University trialstat.com/2023/04/bigfoo… #BigfootBiomedical #ClinicalResearch #ClinicalTrials #HCPs

Akero Therapeutics Announces Positive End-of-Phase 2 Meeting with the FDA and SYNCHRONY Phase 3 Program for Efruxifermin in NASH trialstat.com/2023/04/akero-… #AkeroTherapeutics #ClinicalResearch #ClinicalTrials #Efruxifermin